Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study

Background Management of systemic lupus erythematosus (SLE) is largely guided by organ involvement. Serositis affects up to 46% of patients, yet its treatment is mainly empirical and extrapolated from other manifestations, and long-term outcome data remain limited. We aimed to evaluate short-term re...

Descripció completa

Dades bibliogràfiques

Autors principals:	Laurent Arnaud, Thierry Martin, Anne-Sophie Korganow, Jean Sibilia, Sandrine Jousse-Joulin, Marc Scherlinger, Estibaliz Lazaro, Sebastien Ottaviani, Ludovic Trefond, Laurent Chiche, Elodie Fels, Cassandra Goncalves
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2026-05-01
Col·lecció:	RMD Open
Accés en línia:	https://rmdopen.bmj.com/content/12/2/e006919.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!